首页 | 本学科首页   官方微博 | 高级检索  
     

经新辅助化疗后行间歇性肿瘤细胞减灭治疗晚期原发性卵巢癌患者临床疗效及预后生存分析
引用本文:付岳亚,李功,赵耀. 经新辅助化疗后行间歇性肿瘤细胞减灭治疗晚期原发性卵巢癌患者临床疗效及预后生存分析[J]. 四川解剖学杂志, 2022, 30(1): 48-50. DOI: 10.3969/j.issn.1005-1457.2022.01.016
作者姓名:付岳亚  李功  赵耀
作者单位:南阳市第二人民医院肿瘤科,南阳473009
摘    要:

关 键 词:新辅助化疗  间歇性肿瘤细胞减灭  晚期原发性卵巢癌  预后  临床疗效

Clinical Efficacy of Neoadjuvant Chemotherapy Interval Debulking Surgery in the Treatment of Patients with Advanced Primary Ovarian Cancer and the Analysis on Its Prognostic Survival
FU Yue-ya,LI Gong,ZHAO Yao. Clinical Efficacy of Neoadjuvant Chemotherapy Interval Debulking Surgery in the Treatment of Patients with Advanced Primary Ovarian Cancer and the Analysis on Its Prognostic Survival[J]. Sichuan Journal of Anatomy, 2022, 30(1): 48-50. DOI: 10.3969/j.issn.1005-1457.2022.01.016
Authors:FU Yue-ya  LI Gong  ZHAO Yao
Abstract:
Keywords:
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号